Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/freedom-holding-corp-reports-strong-revenue-growth-in-q3-2025-fiscal-year-driven-by-brokerage-and-banking-segments/